Profile
Sector:
HealthcareIndustry:
Diagnostics & ResearchCountry:
United StatesIPO:
11 August 2016Website:
http://www.medpace.comNext earnings report:
22 July 2024Last dividends:
N/ANext dividends:
N/APrice
after hours | Fri, 28 Jun 2024 22:31:16 GMTDividend
Analysts recommendations
Institutional Ownership
MEDP Latest News
Medpace (MEDP) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
In the latest trading session, Medpace (MEDP) closed at $405.33, marking a -0.53% move from the previous day.
Medpace (MEDP) closed the most recent trading day at $395.95, moving +0.52% from the previous trading session.
The latest trading day saw Medpace (MEDP) settling at $405.68, representing a +1.12% change from its previous close.
Medpace (MEDP) is well positioned to outperform the market, as it exhibits above-average growth in financials.
The latest trading day saw Medpace (MEDP) settling at $390.81, representing a +0.07% change from its previous close.
Medpace (MEDP) is in a strong position to surpass the market due to its above-average financial growth.
Investors frequently rely on recommendations from Wall Street analysts when deciding whether to Buy, Sell, or Hold a stock. Though media coverage of rating changes by these analysts can impact a stock's price, their significance is often questioned.
Medpace (MEDP) has the potential to generate impressive returns due to its strong growth characteristics.
Medpace (MEDP) has the ideal mix of factors that could lead to a positive earnings surprise in its upcoming report. Be ready with the important expectations.
What type of business is Medpace Holdings?
Medpace Holdings, Inc. specializes in conducting contract clinical research for companies in the biotechnology, pharmaceutical, and medical industries. It was founded in 1992. The headquarters is located in Cincinnati, Ohio (USA). Medpace Holdings, Inc. provides a wide range of services: monitoring clinical trials, laboratory analysis, electronic data capture, patient recruitment, and more. The company conducts scientific research on new drugs and medical devices in key therapeutic areas such as cardiology, hematology, oncology, neurology and psychiatry, vaccine development, antibiotics, etc. Clients of Medpace Holdings, Inc. include many leading global pharmaceutical, biotechnology companies, and medical device manufacturers.
What sector is Medpace Holdings in?
Medpace Holdings is in the Healthcare sector
What industry is Medpace Holdings in?
Medpace Holdings is in the Diagnostics & Research industry
What country is Medpace Holdings from?
Medpace Holdings is headquartered in United States
When did Medpace Holdings go public?
Medpace Holdings initial public offering (IPO) was on 11 August 2016
What is Medpace Holdings website?
https://www.medpace.com
Is Medpace Holdings in the S&P 500?
No, Medpace Holdings is not included in the S&P 500 index
Is Medpace Holdings in the NASDAQ 100?
No, Medpace Holdings is not included in the NASDAQ 100 index
Is Medpace Holdings in the Dow Jones?
No, Medpace Holdings is not included in the Dow Jones index
When does Medpace Holdings report earnings?
The next expected earnings date for Medpace Holdings is 22 July 2024